IBDEI1F3 ; ; 20-MAY-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;OCT 15, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,25408,2)
 ;;=Hallucinations^53738
 ;;^UTILITY(U,$J,358.3,25409,0)
 ;;=780.8^^145^1540^87
 ;;^UTILITY(U,$J,358.3,25409,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,25409,1,4,0)
 ;;=4^780.8
 ;;^UTILITY(U,$J,358.3,25409,1,5,0)
 ;;=5^Hyperhidrosis
 ;;^UTILITY(U,$J,358.3,25409,2)
 ;;=Hyperhidrosis^60030
 ;;^UTILITY(U,$J,358.3,25410,0)
 ;;=307.41^^145^1540^99
 ;;^UTILITY(U,$J,358.3,25410,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,25410,1,4,0)
 ;;=4^307.41
 ;;^UTILITY(U,$J,358.3,25410,1,5,0)
 ;;=5^Insomnia, Nonorganic, Transient
 ;;^UTILITY(U,$J,358.3,25410,2)
 ;;=^268285
 ;;^UTILITY(U,$J,358.3,25411,0)
 ;;=780.52^^145^1540^100
 ;;^UTILITY(U,$J,358.3,25411,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,25411,1,4,0)
 ;;=4^780.52
 ;;^UTILITY(U,$J,358.3,25411,1,5,0)
 ;;=5^Insomnia, Organic
 ;;^UTILITY(U,$J,358.3,25411,2)
 ;;=Insomnia, Organic^87662
 ;;^UTILITY(U,$J,358.3,25412,0)
 ;;=302.71^^145^1540^103
 ;;^UTILITY(U,$J,358.3,25412,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,25412,1,4,0)
 ;;=4^302.71
 ;;^UTILITY(U,$J,358.3,25412,1,5,0)
 ;;=5^Loss of Libido
 ;;^UTILITY(U,$J,358.3,25412,2)
 ;;=^268178
 ;;^UTILITY(U,$J,358.3,25413,0)
 ;;=785.6^^145^1540^106
 ;;^UTILITY(U,$J,358.3,25413,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,25413,1,4,0)
 ;;=4^785.6
 ;;^UTILITY(U,$J,358.3,25413,1,5,0)
 ;;=5^Lymphadenopathy
 ;;^UTILITY(U,$J,358.3,25413,2)
 ;;=Lymphadenopathy^72368
 ;;^UTILITY(U,$J,358.3,25414,0)
 ;;=728.85^^145^1540^112
 ;;^UTILITY(U,$J,358.3,25414,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,25414,1,4,0)
 ;;=4^728.85
 ;;^UTILITY(U,$J,358.3,25414,1,5,0)
 ;;=5^Muscle Spasm
 ;;^UTILITY(U,$J,358.3,25414,2)
 ;;=Muscle Spasm^112558
 ;;^UTILITY(U,$J,358.3,25415,0)
 ;;=782.0^^145^1540^51
 ;;^UTILITY(U,$J,358.3,25415,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,25415,1,4,0)
 ;;=4^782.0
 ;;^UTILITY(U,$J,358.3,25415,1,5,0)
 ;;=5^Disturbance of Skin Sensation
 ;;^UTILITY(U,$J,358.3,25415,2)
 ;;=Disturbance of Skin Sensation^35757
 ;;^UTILITY(U,$J,358.3,25416,0)
 ;;=278.00^^145^1540^117
 ;;^UTILITY(U,$J,358.3,25416,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,25416,1,4,0)
 ;;=4^278.00
 ;;^UTILITY(U,$J,358.3,25416,1,5,0)
 ;;=5^Obesity
 ;;^UTILITY(U,$J,358.3,25416,2)
 ;;=Obesity^84823
 ;;^UTILITY(U,$J,358.3,25417,0)
 ;;=278.01^^145^1540^118
 ;;^UTILITY(U,$J,358.3,25417,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,25417,1,4,0)
 ;;=4^278.01
 ;;^UTILITY(U,$J,358.3,25417,1,5,0)
 ;;=5^Obesity, Morbid
 ;;^UTILITY(U,$J,358.3,25417,2)
 ;;=Obesity, Morbid^84844
 ;;^UTILITY(U,$J,358.3,25418,0)
 ;;=783.5^^145^1540^127
 ;;^UTILITY(U,$J,358.3,25418,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,25418,1,4,0)
 ;;=4^783.5
 ;;^UTILITY(U,$J,358.3,25418,1,5,0)
 ;;=5^Polydipsia
 ;;^UTILITY(U,$J,358.3,25418,2)
 ;;=Polydipsia^186699
 ;;^UTILITY(U,$J,358.3,25419,0)
 ;;=783.6^^145^1540^128
 ;;^UTILITY(U,$J,358.3,25419,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,25419,1,4,0)
 ;;=4^783.6
 ;;^UTILITY(U,$J,358.3,25419,1,5,0)
 ;;=5^Polyphagia
 ;;^UTILITY(U,$J,358.3,25419,2)
 ;;=Polyphagia^60236
 ;;^UTILITY(U,$J,358.3,25420,0)
 ;;=780.2^^145^1540^144
 ;;^UTILITY(U,$J,358.3,25420,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,25420,1,4,0)
 ;;=4^780.2
 ;;^UTILITY(U,$J,358.3,25420,1,5,0)
 ;;=5^Syncope and Collapse
 ;;^UTILITY(U,$J,358.3,25420,2)
 ;;=^116707
 ;;^UTILITY(U,$J,358.3,25421,0)
 ;;=783.1^^145^1540^156
 ;;^UTILITY(U,$J,358.3,25421,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,25421,1,4,0)
 ;;=4^783.1
 ;;^UTILITY(U,$J,358.3,25421,1,5,0)
 ;;=5^Weight gain, abnormal
 ;;^UTILITY(U,$J,358.3,25421,2)
 ;;=^998
 ;;^UTILITY(U,$J,358.3,25422,0)
 ;;=783.21^^145^1540^157
